17alpha-acetoxy-11beta-(4-N,N-dimethylaminophenyl)-19-norpregna-4,9-diene-3,20-dione,
CDB 2914,
CDB-2914,
HRP 2000,
HRP-2000,
RTI-3021-012,
RTI-3021-022,
ulipristal,
VA-2914,
VA2914,
Ulipristal,
159811-51-5,
Uliprisnil,
UNII-6J5J15Q2X8,
6J5J15Q2X8,
C28H35NO3,
(8S,11R,13S,14S,17R)-17-acetyl-11-(4-(dimethylamino)phenyl)-17-hydroxy-13-methyl-6,7,8,11,12,13,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3(2H)-one,
ellae,
Ulipristal [USAN:INN:BAN],
PGL 4001,
VA-2914,
Deacetyl CDB 2914,
Ulipristal (USAN/INN),
SCHEMBL545159,
CHEMBL2103846,
HKDLNTKNLJPAIY-WKWWZUSTSA-N,
(8S,11R,13S,14S,17R)-17-acetyl-11-[4-(dimethylamino)phenyl]-17-hydroxy-13-methyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one,
AMX10182,
CDB 3236,
2779AH,
EBD146589,
s3081,
ZINC34089131,
AKOS025401807,
API0013849,
DB08867,
AC-25786,
FT-0675730,
D09567,
(8S,11R,13S,14S,17R)-17-acetyl-11-(4-(dime,
11beta-(4-(Dimethylamino)phenyl)-17-hydroxy-19-norpregna-4,9-diene-3,20-dione,
11beta-(4-N,N-dimethylaminophenyl)-17alpha-hydroxy-19-norpregna-4,9-diene-3,20-dione,
11beta-[4-(N,N-dimethylamino)-phenyl]-17alpha-hydroxy-19-norpregn-4,9-diene-3,20-dione;,
19-Norpregna-4,9-diene-3,20-dione,11-[4-(dimethylamino)phenyl]-17-hydroxy-, (11b)-,
(8S,11R,13S,14S,17R)-17-acetyl-11-(4-(dimethylamino)phenyl)-17-hydroxy-13-methyl-1,2,6,7,8,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one,
thylamino)phenyl)-17-hydroxy-13-methyl-1,2,6,7,8,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one,
Esmya,
Ulipristal acetate,
Ulipristal [INN],
Ella (TN),
Ulipristal [USAN:INN],
D0V4WD,
CDB-2914,
HRP 2000,
VA 2914,
ACN-053816,
RTI-3021-012,
B2134,
(11|A)-11-[4-(Dimethylamino)phenyl]-17-hydroxy-19-norpregna-4,9-diene-3,20-dione,
(11beta)-11-[4-(Dimethylamino)phenyl]-17-hydroxy-19-norpregna-4,9-diene-3,20-dione,
11-[4-(N,N-dimethylamino)-phenyl]-17-hydroxy-19-norpregna-4,9-diene-3,20-dione,
11beta-[4-(N,N-diMethylaMino)-phenyl]-17alpha-hydroxy-19-norpregna-4,9-diene-3,20-dione,